Catalyst Wire Dossier Catalyst Wire Dossier

Port Delivery System (PDS) with ranibizumab

ranibizumab · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Port Delivery System (PDS) with ranibizumab, covering 2026-04-27 to 2026-06-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME [Phase 3]

See pricing